Surgical procedure | Cholecystectomy | Hysterectomy | Mastectomy | Orthopedic arthroplasty surgery | Spinal Surgery | Thoracic surgery | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Outcomes | Reduction (mm)/RR Estimate (95% CI; p-value; trials) | Test for subgroup differences P-value | Reduction (mm)/RR Estimate (95% CI; p-value; trials) | Test for subgroup differences P-value | Reduction (mm)/RR Estimate (95% CI; p-value; trials) | Test for subgroup differences P-value | Reduction (mm)/RR Estimate (95% CI; p-value; trials) | Test for subgroup differences P-value | Reduction (mm)/RR Estimate (95% CI; p-value; trials) | Test for subgroup differences P-value | Reduction (mm)/RR Estimate (95% CI; p-value; trials) | Test for subgroup differences P-value |
Beneficial outcomes | ||||||||||||
6-h VAS at rest Low risk of bias | 26.0 mm (24.8, 27.2; 1 trial) | - | 3.0 mm (−12.9, 18.9; 1 trial) | - | - | - | - | - | - | - | 5.0 mm (−0.7, 10.7; 2 trials) | P = 0.36 |
6-h VAS at rest All trials | 13.6 mm (95% CI: −6.2, 33.4; p = 0.18; 3 trials; TSA adj. CI: -; 4.4%) | P = 0.87 | 16.4 mm (95% CI: 11.9, 21.0; p < 0.00001; 16 trials; TSA adj. CI: 11.9, 21.0; 104.3%) | P = 0.05 | 7.8 mm (95% CI: 1.9, 13.7; p = 0.01; 7 trials; TSA adj. CI: −1.1, 16.7; 51.9%) | P = 0.15 | Not estimable | - | 10.2 mm (95% CI: 2.3, 18.0; p = 0.01; 7 trials; TSA adj. CI: −5.7, 26.0; 29.6%) | P = 0.59 | 6.6 mm (95% CI: 0.8, 12.4; p = 0.05; 6 trials; TSA adj.CI: −3.0, 12.3; 59.2%) | P = 0.02 |
6-h VAS at mobilization Low risk of bias | 11.5 mm (10.3, 12.7; 1 trial) | - | 13.0 mm (−26.0, 52.0; 1 trial) | - | - | - | - | - | - | - | 8.9 mm (1.6, 16.1; 1 trial) | - |
6-h VAS at mobilization All trials | 11.5 mm (95%CI: 10.3, 12.7; p < 0.00001; 1 trial; TSA adj. CI: -) | P = 0.04 | 8.5 mm (95%CI: 2.8, 14.2; p = 0.004; 6 trials; TSA adj.CI: 0.2, 16.7; 56.1%) | P = 0.97 | 5.2 mm (95%CI: −1.6, 12.0; p = 0.14; 6 trials; TSA adj.CI: −5.1, 15.7; 44.8%) | P = 0.07 | Not estimable | - | 10.0 mm (95%CI: 1.1, 19.0; p = 0.03; 1 trial; TSA adj. CI: -) | P = 0.73 | 10.9 mm (95%CI: 4.4, 17.4; p = 0.001; 4 trials; TSA adj.CI: 0.1, 21.7; 42.8%) | P = 0.41 |
24-h VAS at rest Low risk of bias | 7.0 mm (5.8, 8.2; 1 trial) | - | 9.0 mm (−2.8, 20.8; 1 trial) | - | - | - | 0.9 mm (−6.3, 8.1; 1 trial) | - | - | - | 4.2 mm (−0.2, 8.5; 2 trials) | P = 0.06 |
24-h VAS at rest All trials | 3.2 mm (95% CI: −1.9, 8.4; p = 0.22; 3 trials; TSA adj.CI: −3.3, 9.8; 69.1%) | P = 0.1 | 10.5 mm (95% CI: 6.9, 14.2; p < 0.00001; 15 trials; TSA adj.CI: 6.7, 14.4; 136.3%) | P = 0.02 | 2.6 mm (95% CI: −3.2, 8.5; p = 0.2; 3 trials; TSA adj. CI: −3.2, 8.5; 112.9%) | P = 0.02 | 1.0 mm (95% CI: −1.7, 3.7; p = 0.45; 3 trials; TSA adj.CI: −3.9, 6.0; 248.0%) | P = 0.001 | 6.2 mm (95% CI: 0.9, 11.6; p = 0.02; 6 trials; TSA adj.CI: 0.9, 13.3; 64.1%) | P = 0.61 | 9.7 mm (95% CI: 2.4, 17.1; p = 0.01; 8 trials; TSA adj.CI: −4.2, 23.7; 33.6%) | P = 0.51 |
24-h VAS at mobilization Low risk of bias | 16.0 mm (15.1, 16.9; 1 trial) | - | 0.5 mm (−36.5, 37.5; 1 trial) | - | - | - | 0.5 mm (−11.4, 12.3; 1 trial) | - | - | - | 0.1 mm (−8.9, 9.1; 1 trial) | - |
24-h VAS at mobilization All trials | 16.0 mm (95% CI: 15.1, 16.9; p < 0.0001; 1 trial; TSA adj. CI: -) | P < 0.00001 | 7.7 mm (95% CI: −8.2, 23.6; p = 0.34; 5 trials; TSA adj.CI: −16.3, 25.4; 22.5%) | P = 0.91 | 3.1 mm (95% CI: −13.6, 19.8; p = 0.72; 3 trials; −65.1, 71.3; 6.5%) | P = 0.87 | Increase 6.5 mm (95% CI: 3.0, 9.9; p = 0.0002; 2 trials; TSA adj.CI: +2.5, +10.5; 150.7%) | P = 0.0008 | Not estimable | - | 3.0 mm (95% CI: −4.5, 10.4; p = 0.43; 6 trials; TSA adj.CI: −11.2, 17.1; 33.1%) | P = 0.86 |
Harmful outcomes | ||||||||||||
Nausea Low risk of bias | - | - | - | - | - | - | 0.8 (0.6,1.0; 2 trials) | P = 0.5 | - | - | 0.7 (0.5, 0.9; 1 trial) | - |
Nausea All trials | 0.5 (95% CI: 0.25, 0.99; p = 0.05; 1 trial; TSA adj. CI: -) | P = 0.16 | 0.77 (95% CI: 0.63, 0.95; p = 0.01; 11 trials; TSA adj. CI: 0.6, 1.1; 49.4%) | P = 0.73 | 1.38 (95% CI: 0.85, 2.23; p = 0.19; 3 trials; TSA adj. CI: -; 2.69%) | P = 0.33 | 0.83 (95% CI: 0.66, 1.03; p = 0.08; 4 trials; TSA adj. CI: -; 79.7%) | P = 0.91 | 1.07 (95% CI: 0.68, 1.68; p = 0.78; 8 trials; TSA adj. CI: 0.4, 3.2; 22.8%) | P = 0.29 | 0.66 (95% CI: 0.5, 0.88; p = 0.005; 5 trials; TSA adj. CI: 0.4, 1.0; 49.9%) | P = 0.1 |
Vomiting Low risk of bias | - | - | - | - | - | - | - | - | - | - | 1.1 (0.7, 1.6; 1 trial) | - |
Vomiting All trials | 0.5 (95%CI: 0.21, 1.16; p = 0.11; 1 trial; TSA adj. CI: -) | P = 0.28 | 0.71 (95% CI: 0.57, 0.9; p = 0.005; 9 trials; TSA adj. CI: 0.5, 1.0; 71.7%) | P = 0.61 | 0.81 (95% CI: 0.48, 1.37; p = 0.44; 5 trials; TSA adj. CI: 0.1, 6.9; 16.5%) | P = 0.92 | 0.64 (95% CI: 0.26, 1.59; p = 0.34; 1 trial; TSA adj. CI: -) | P = 0.66 | 0.61 (95% CI: 0.33, 1.12; p = 0.11; 7 trials; TSA adj. CI: 0.2, 2.3; 18.6%) | P = 0.51 | 1.01 (95% CI: 0.69, 1.49; p = 0.96; 5 trials; TSA adj. CI: 0.2, 4.9; 8.0%) | P = 0.32 |
Sedation Low risk of bias | 1.8 (0.8, 3.9; 1 trial) | - | 0.8 (0.4, 1.6; 1 trial) | - | - | - | 0.9 (0.7, 1.2; 1 trial) | - | - | - | 1.2 (0.7, 2.3; 2 trials) | P = 0.55 |
Sedation All trials | 3.28 (95% CI: 1.55, 6.94; p = 0.002; 5 trials; TSA adj. CI: -; 3.9%) | P = 0.009 | 1.08 (95% CI: 0.81, 1.45; p = 0.61; 7 trials; TSA adj. CI: 0.5, 2.2; 23.2%) | P = 0.06 | 1.04 (95% CI: 0.75, 1.44; p = 0.83; 2 trials; TSA adj. CI: -; 4.8%) | P = 0.06 | 0.97 (95% CI: 0.76, 1.24; p = 0.82; 2 trials; TSA adj. CI: 0.7, 1.6; 44.3%) | P = 0.01 | 2.65 (95% CI: 0.94, 7.52; p = 0.07; 7 trials; TSA adj. CI: -; 2.3%) | P = 0.19 | 1.34 (95% CI: 0.78, 2.32; p = 0.29; 5 trials; TSA adj. CI: 0.1, 12.5; 10.8%) | P = 0.68 |
Dizziness Low risk of bias | 1.0 (0.7, 1.4; 1 trial) | - | 6.2 (1.1, 34.0; 1 trial) | - | - | - | 0.7 (0.2, 2.1; 1 trial) | - | - | - | 1.0 (0.8, 1.3; 2 trials) | P = 0.64 |
Dizziness All trials | 0.7 (95% CI: 0.52, 0.94; p = 0.02; 6 trials; TSA adj. CI: 0.2, 2.6; 27.1%) | P = 0.01 | 1.34 (95% CI: 0.95, 1.89; p = 0.1; 11 trials; TSA adj. CI: 0.3, 5.6; 16.8%) | P = 0.2 | 1.03 (95% CI: 0.74, 1.43; p = 0.88; 5 trials; TSA adj. CI: 0.6, 2.1; 31.4%) | P = 0.84 | 0.72 (95% CI: 0.32, 1.66; p = 0.45; 3 trials; TSA adj. CI: 0.0, 18.1; 5.6%) | P = 0.44 | 1.49 (95% CI: 0.77, 2.86; p = 0.24; 6 trials; TSA adj. CI: 0.6, 3.1; 31.4%) | P = 0.22 | 1.04 (95% CI: 0.85, 1.26; p = 0.7; 4 trials; TSA adj. CI: 0.7, 1.5; 36.4%) | P = 0.66 |